Nyxoah S.A. (NYXH) NASDAQ
3.08
+0.01(+0.33%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.08
+0.01(+0.33%)
Currency In USD
Address
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Belgium
Phone
32 1 022 23 55
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
183
First IPO Date
April 28, 2021
| Name | Title | Pay | Year Born |
| Olivier Taelman | Chief Executive Officer & Executive Director | 1.03M | 1972 |
| Robert Taub | Co-Founder & Chairman | 139,645 | 1947 |
| Loic Moreau | President of International | 552,029 | 1980 |
| Bruno Onkelinx | Chief Technical Officer | 1.76M | 1972 |
| Jeyakumar Subbaroyan | Chief Science Officer | 0 | N/A |
| Remi Renard | Chief of Staff | 0 | N/A |
| Scott Holstine | Chief Commercial Officer | 0 | 1971 |
| An Moonen | General Counsel | 0 | N/A |
| Geeta Kaveti | Chief Compliance Officer | 0 | N/A |
| Maggie McGowan | Chief HR Officer | 0 | N/A |
| Pearson Dennis | Investor Relations Associate | 0 | N/A |
| Maurits S. Boon | Chief Medical Officer | 0 | N/A |
| John Landry | Chief Financial Officer | 0 | 1973 |
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.